Hepatitis B virus e antigen and viral persistence

2021 ◽  
Vol 51 ◽  
pp. 158-163
Author(s):  
Kuen-Nan Tsai ◽  
Jing-Hsiung James Ou
Hepatology ◽  
2017 ◽  
Vol 67 (1) ◽  
pp. 56-70 ◽  
Author(s):  
Gaiyun Li ◽  
Yuanfei Zhu ◽  
Dianhui Shao ◽  
Hao Chang ◽  
Xiaoming Zhang ◽  
...  

2004 ◽  
Vol 78 (20) ◽  
pp. 11258-11262 ◽  
Author(s):  
Chloe L. Thio ◽  
Timothy L. Mosbruger ◽  
Richard A. Kaslow ◽  
Christopher L. Karp ◽  
Steffanie A. Strathdee ◽  
...  

ABSTRACT Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an inhibitory T-cell receptor expressed by activated and regulatory T cells. We hypothesized that single-nucleotide polymorphisms (SNPs) in the gene encoding CTLA-4 may affect the vigor of the T-cell response to hepatitis B virus (HBV) infection, thus influencing viral persistence. To test this hypothesis, we genotyped six CTLA4 SNPs, from which all frequent haplotypes can be determined, using a large, matched panel of subjects with known HBV outcomes. Haplotypes with these SNPs were constructed for each subject using PHASE software. The haplotype distribution differed between those with viral persistence and those with clearance. Two haplotypes were associated with clearance of HBV infection, which was most likely due to associations with the SNPs −1722C (odds ratio [OR] = 0.60, P = 0.06) and +49G (OR = 0.73, P = 0.02). The wild-type haplotype, which contains an SNP leading to a decreased T-cell response (+6230A), was associated with viral persistence (OR = 1.32, P = 0.04). These data suggest that CTLA4 influences recovery from HBV infection, which is consistent with the emerging role of T regulatory cells in the pathogenesis of disease.


2010 ◽  
Vol 107 (20) ◽  
pp. 9340-9345 ◽  
Author(s):  
Y.-J. Lin ◽  
L.-R. Huang ◽  
H.-C. Yang ◽  
H.-T. Tzeng ◽  
P.-N. Hsu ◽  
...  

2008 ◽  
Vol 136 (1-2) ◽  
pp. 166-174 ◽  
Author(s):  
Gil-Soon Park ◽  
Hee-Young Kim ◽  
Hyun-Soo Shin ◽  
Sun Park ◽  
Ho-Joon Shin ◽  
...  

Hepatology ◽  
2018 ◽  
Vol 67 (5) ◽  
pp. 1695-1709 ◽  
Author(s):  
Avishek Kumar Singh ◽  
Sheetalnath Babasaheb Rooge ◽  
Aditi Varshney ◽  
Madavan Vasudevan ◽  
Ankit Bhardwaj ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Fenglin Zhao ◽  
Xiaoyu Xie ◽  
Xu Tan ◽  
Hongli Yu ◽  
Miaomiao Tian ◽  
...  

About 250 million people worldwide are chronically infected with Hepatitis B virus (HBV), contributing to a large burden on public health. Despite the existence of vaccines and antiviral drugs to prevent infection and suppress viral replication respectively, chronic hepatitis B (CHB) cure remains a remote treatment goal. The viral persistence caused by HBV is account for the chronic infection which increases the risk for developing liver cirrhosis and hepatocellular carcinoma (HCC). HBV virion utilizes various strategies to escape surveillance of host immune system therefore enhancing its replication, while the precise mechanisms involved remain elusive. Accumulating evidence suggests that the proteins encoded by HBV (hepatitis B surface antigen, hepatitis B core antigen, hepatitis B envelope antigen, HBx and polymerase) play an important role in viral persistence and liver pathogenesis. This review summarizes the major findings in functions of HBV encoding proteins, illustrating how these proteins affect hepatocytes and the immune system, which may open new venues for CHB therapies.


Sign in / Sign up

Export Citation Format

Share Document